Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. [electronic resource] by
- Ahmed, K A
- Abuodeh, Y A
- Echevarria, M I
- Arrington, J A
- Stallworth, D G
- Hogue, C
- Naghavi, A O
- Kim, S
- Kim, Y
- Patel, B G
- Sarangkasiri, S
- Johnstone, P A S
- Sahebjam, S
- Khushalani, N I
- Forsyth, P A
- Harrison, L B
- Yu, M
- Etame, A B
- Caudell, J J
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|